Mission, Vision, Values

History

Quick Facts

Strategic Initiatives

Our media and press kit contains the information you need to share
stories of discovery and communicate science to the public in a timely
fashion.

Our Mission

To comprehensively and systematically characterize mechanisms of action underlying infectious, metabolic and immune-mediated diseases; the NIMML will translate this new knowledge towards developing innovative therapeutics for human diseases that are safer and more effective.

Our Vision

To become a world leading research laboratory in translational, personalized, predictive, participatory, and preventive medicine.

Our Values

About NIMML

The NIMML uses innovation to tackle challenges in infectious, immune-mediated and chronic inflammatory disease research. We combine computational approaches with pre-clinical and clinical experimentation to transition new biological knowledge into safer and more effective medicines for human diseases.

NIMML History

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) is a research organization founded in 2002 under the guidance of Dr. Bassaganya-Riera and Dr. Hontecillas. NIMML is committed to a transdisciplinary, team-science approach with a personalized medicine focus at the interface of immunology, inflammation and nutrition. The NIMML research programs incorporate drug development, nutritional immunology, computational immunology, and translational research in immune mediated, infectious and chronic inflammatory diseases.

The NIMML research has pioneered pipelines applying high-throughput computational and experimental immunology techniques and system biology approaches in translational immunology research and discovery. Through the Center for Modeling Immunity to Enteric Pathogens Program, we have applied high performance computing techniques to model and simulate human immunology systems and help immunologists conduct in silico experiments in order to develop a more mechanistic experimental design, validate hypotheses and save significant time and laboratory cost.

5. Enabling students to excel in translational research and reach their career goals in environments such as Amazon, QIAGEN, University of California Berkley, Feinstein

6. Creating innovative pipelines for drug development to identify and test the efficacy and safety of new compounds by applying molecular and systems modeling, testing the mechanism of action in animal models of disease, and conducting human clinical trials to validate the results of animal models